Thermo Fisher Scientific Inc.

NYSE (USD): Thermo Fisher Scientific Inc. (TMO)

Last Price

524.049

Today's Change

+7.36 (1.42%)

Day's Change

515.00 - 526.43

Trading Volume

2,310,186

Overview

Market Cap

200 Billion

Shares Outstanding

382 Million

Avg Volume

1,708,995

Avg Price (50 Days)

545.96

Avg Price (200 Days)

574.30

PE Ratio

32.86

EPS

15.95

Earnings Announcement

31-Jan-2025

Previous Close

516.69

Open

516.69

Day's Range

515.0 - 526.43

Year Range

493.3 - 627.88

Trading Volume

1,417,719

Price Change Highlight

1 Day Change

1.42%

5 Day Change

-0.62%

1 Month Change

1.54%

3 Month Change

-14.61%

6 Month Change

-7.18%

Ytd Change

-3.69%

1 Year Change

-0.48%

3 Year Change

-18.79%

5 Year Change

59.75%

10 Year Change

306.46%

Max Change

41491.27%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment